Pre-Commercial Procurement for Cancer Care
Funds €8–10M procurer consortia to bring affordable cancer technologies, devices and medicines from tender to patient benefit.
Healthcare systems need affordable innovations that improve cancer diagnosis and treatment, but suppliers often lack the first customer references and real-world evidence needed to bring them to market. This topic funds public procurer consortia to run a pre-commercial procurement process for shared needs in cancer technologies, medical devices or medicines.
The solutions must be clinically valid…
Fund consortia of public procurers with common healthcare needs to run pre-commercial procurement for affordable, innovative cancer technologies, medical devices or medicines. Solutions must be clinically validated, piloted or upscaled by procurers in at least five EU or Associated Countries. Involve patients, caregivers, clinicians and other end-users; hold an open-market consultation before the tender; promote the tender widely; declare interest in purchasing at least one successful solution; and provide capacity building so other healthcare procurers can adopt PCP.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up